The involvement of ventral tegmental area cholinergic muscarinic receptors in classically conditioned fear expression as measured with fear- potentiated startle

Brain Research

Volumn 870, Issue 1-2, 2000, Pages 135-141

  Greba, Quentin ^a   Munro, Laurie J ^b   Kokkinidis, Larry ^a  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Acetylcholine; Fear potentiated startle; Laterodorsal and pedunculopontine tegmental nuclei; Mesoamygdaloid dopamine system; Muscarinic receptors; Ventral tegmental area, Methylscopolamine

Indexed keywords

CHOLINERGIC RECEPTOR; METHYLSCOPOLAMINE; MUSCARINIC RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUDITORY STIMULATION; CONDITIONING; CONTROLLED STUDY; FEAR; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; SHOCK; STARTLE REFLEX; TASK PERFORMANCE;

ACETYLCHOLINE; ACOUSTIC STIMULATION; AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; CONDITIONING, CLASSICAL; DOPAMINE; FEAR; MALE; MICROINJECTIONS; MUSCARINIC ANTAGONISTS; PONS; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; SCOPOLAMINE; STARTLE REACTION; VASODILATOR AGENTS; VENTRAL TEGMENTAL AREA;

EID: 0034617406     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02414-8     Document Type: Article

References (50)

1. Beck C.H.M., Fibiger H.C. Conditioned fear-induced changes in behavior with the expression of the immediate early gene c-fos: with or without diazepam pretreatment. J. Neurosci. 15:1995;709-720.
2. Bernardini G.L., Gu X., German D.C. Nucleus A10 dopaminergic neurons in inbred mouse strains: firing rate and autoreceptor sensitivity are independent of the number of cells in the nucleus. Brain Res. Bull. 27:1991;163-168.
3. Blackburn J.R., Pfaus J.G., Phillips A.G. Dopamine functions in appetitive and defensive behaviors. Prog. Neurobiol. 39:1992;247-279.
4. Blaha C.D., Allen L.F., Das S., Inflis W.L., Latimer M.P., Vincent S.R., Winn P. Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterdorsal tegmental nucleus-lesioned rats. J. Neurosci. 16:1996;714-722.
5. Borowski T.B., Kokkinidis L. Contribution of ventral tegmental area dopamine neurons to expression of conditional fear: effects of electrical stimulation, excitotoxin lesions, and quinpirole infusion on potentiated startle in rats. Behav. Neurosci. 110:1996;1349-1364.
6. Campeau S., Watson S.J. Neuroendocrine and behavioral responses and brain pattern of c-fos induction associated with audiogenic stress. J. Neuroendocrinol. 9:1997;577-588.
7. M.L. Coco, C.M. Kuhn, T.D. Ely, C.D. Kilts, Selective activation of mesoamygdaloid neurons by conditioned stress: attenuation by diazepam, Brain Res. (1992) 39-47.
8. A. Dahlstrom, K. Fuxe, Evidence for the existence of monoamine-containing neurons in the central nervous system, Acta Physiol. Scand. (1964) 1-55.
9. Davis M. The role of the amygdala in conditioned fear. Aggleton J.P. The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. 1992;255-306 Wiley-Liss, New York.
10. Davis M., Astrachan D.I. Conditioned fear and startle magnitude: effects of different footshock or backshock intensities used in training. J. Exp. Psychol.: Animal Behav. Processes. 4:1978;95-103.
11. Deutch A.Y., Tam S.Y., Roth R.H. Footshock and conditioned stress increase 3,4 dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not the substantia nigra. Brain Res. 333:1985;143-146.
12. D.L. Gelowitz, L. Kokkinidis, Enhanced amygdala kindling after electrical stimulation of the ventral tegmental area: implications for fear and anxiety, J. Neurosci. 19 (1999) RC41(1-5).
13. 1 receptor antagonist SCH 23390 blocks fear-potentiated startle but not shock reactivity or the shock sensitization of acoustic startle, Behav. Neuorsci. (2000) in press.
14. Guarraci F.A., Frohardt R.J., Kapp B.S. Amygdaloid D1 dopamine receptor involvement in pavlovian fear conditioning. Brain Res. 827:1999;28-40.
15. Guarraci F.A., Kapp B.S. An electrophysiological characterization of ventral tegmental area dopaminergic neurons during differential pavlovian fear conditioning in the awake rabbit. Behav. Brain Res. 99:1999;169-179.
16. Hallanger A.E., Wainer B.H. Ascending projections from the pedunculopontine tegmental nucleus and the adjacent mesopontine tegmentum in the rat. J. Comp. Neurol. 274:1988;483-515.
17. Innes I.R., Nickerson M. Atropine, scopolamine, and related antimuscarinic drugs. Goodman L.S., Gilman A. The Pharmacological Basis of Therapeutics. 5th Edition :1975;514-532 McMillan, New York.
18. Jackson A., Crossman A.R. Nucleus tegmenti pedunculopontinus: efferent connections with special reference to the basal ganglia studied in the rat by anterograde and retrograde transport of horseradish peroxidase. Neuroscience. 10:1983;725-765.
19. Johnson S.W., North R.A. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J. Physiol. (London). 450:1992;455-468.
20. Kalivas P.W. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Rev. 18:1993;75-113.
21. Kelland M.D., Freeman A.S., Rubin J., Chiodo L.A. Ascending afferent regulation of rat midbrain dopamine neurons. Brain Res. Bull. 31:1993;539-546.
22. Kofman O., McGlynn S.M., Olmstead M.C., Yeomans J.S. Differential effects of atropine, procaine and dopamine in the rat ventral tegmentum on lateral hypothalamic rewarding brain stimulation. Behav. Brain Res. 38:1990;55-68.
23. Kofman O., Yeomans J.S. Cholinergic antagonists in ventral tegmentum elevate thresholds for lateral hypothalamic and brainstem self-stimulation. Pharmacol. Biochem. Behav. 31:1989;547-559.
24. Lacey M.G., Calabresi P., North R.A. Muscarine depolarizes rat substantia nigra zona compacta and ventral tegmental neurons in vitro through M1-like receptors. J. Pharmacol. Exp. Ther. 253:1990;395-400.
25. Lavoie B., Parent A. Pedunculopontine nucleus in the squirrel monkey: distribution of cholinergic and monoaminergic neurons in the mesopontine tegmentum with evidence for the presence of glutamate in cholinergic neurons. J. Comp. Neurol. 344:1994;190-209.
26. LeDoux J. Fear and the brain: where have we been, and where are we going. Biol. Psychiat. 44:1998;1229-1238.
27. Lokwan S.J.A., Overton P.G., Berry M.S., Clark D. Stimulation of the pedunculopontine tegmental nucleus in the rat produces burst firing in A9 dopaminergic neurons. Neuroscience. 92:1999;245-254.
28. Munro L.J., Kokkinidis L. Infusion of quinpirole and muscimol into the ventral tegmental area inhibits fear-potentiated startle: implications for the role of dopamine in fear expression. Brain Res. 746:1997;231-238.
29. Oades R.D., Halliday G.M. Ventral tegmental (A10) system: Neurobiology. 1. Anatomy and connectivity. Brain Res. Rev. 12:1987;117-165.
30. Oakman S.A., Faris P.L., Kerr P.E., Cozzari C., Hartman B.K. Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area. J. Neurosci. 15:1995;5959-5969.
31. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic, New York.
32. Salamone J.D. The involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behav. Brain Res. 61:1994;117-133.
33. Seutin V., Verbanck P., Massotte L., Dresse A. Evidence for the presence of N-methyl-D-aspartate receptors in the ventral tegmental area of the rat: an electrophysiological in vitro study. Brain Res. 514:1990;147-150.
34. Stevens J.R., Livermore A. Kindling of the mesolimbic dopamine system: animal model of psychosis. Neurology. 28:1978;36-46.
35. Stevens J.R., Wilson K., Foote W. GABA blockade, dopamine and schizophrenia: experimental studies in the cat. Psychopharmacologia (Berlin). 39:1974;105-119.
36. Swanson L.W. The projections of the ventral tegmental area and adjacent regions: a combined fluorescence retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 9:1982;321-353.
37. 1 receptor antagonist SCH 23390 into the amygdala blocks fear expression in a potentiated startle paradigm. Brain Res. 795:1998;128-136.
38. Walker D.L., Cassella J.V., Lee Y., De Lima T.C.M., Davis M. Opposing roles of the amygdala and dorsolateral periaqueductal gray in fear-potentiated startle. Neurosci. Biobehav. Rev. 21:1997;743-753.
39. Wang T., French E.D. Electrophysiological evidence for the existence of NMDA and non-NMDA receptors on rat ventral tegmental dopamine neurons. Synapse. 13:1993;270-277.
40. Westerink B.H.C., Kwint H.-F., DeVries J.B. The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. J. Neurosci. 16:1996;2605-2611.
41. White F.J. Synaptic regulation of mesocorticolimbic dopamine neurons. Ann. Re. Neurosci. 19:1996;405-436.
42. White F.J., Wang R.Y. A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists. Life Sci. 34:1984;1161-1170.
43. Willick M.L., Kokkinidis L. Cocaine enhances the expression of fear-potentiated startle: evaluation of state-dependent extinction and the shock-sensitization of acoustic startle. Behav. Neurosci. 109:1995;929-938.
44. A Wise R., Hoffman D.C. Localization of drug reward mechanisms by intracranial injections. Synapse. 10:1992;247-263.
45. Wolf P., Olpe H.-R., Avrith D., Haas H.L. Gabaergic inhibition of neurons in the ventral tegmental area. Experientia. 34:1978;73-74.
46. Woolf N.J. Cholinergic systems in mammalian brain and spinal cord. Prog Neurobiol. 37:1991;475-524.
47. Yeomans J.S. Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia. Neuropsychopharmacology. 12:1995;3-16.
48. Yeomans J., Baptista M. Both nicotinic and muscarinic receptors in ventral tegmental area contribute to brain stimulation reward. Pharmacol. Biochem. Behav. 57:1997;915-921.
49. Yeomans J.S., Kofman O., McFarlane V. Cholinergic involvement in lateral hypothalamic rewarding brain stimulation. Brain Res. 329:1985;19-26.
50. Young S.L., Bohenek D.L., Fanselow M.S. Scopolamine impairs acquisition and facilitates consolidation of fear conditioning: differential effects for tone Vs context conditioning. Neurobiol. Learn. Mem. 63:1995;174-180.